Analysts expect Vivos Therapeutics, Inc. to report revenue of 5.81 M for Q3 26, against a range of 5.36 M to 6.27 M. The most recent reported quarter, Q2 26, came in at 5.15 M, a 13.9% miss against the 5.98 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.90 M | 3.70 M | 3.02 M | 3.82 M | 6.78 M | 3.82 M | 5.14 M | 5.15 M | - | - | - | - | - | - | - | - | ||
| High Estimate | 4.22 M | 3.87 M | 3.79 M | 3.66 M | 4.86 M | 8.23 M | 4.53 M | 6.27 M | 6.27 M | 6.68 M | 5.56 M | 6.59 M | 10.10 M | 11.12 M | 9.05 M | 8.99 M | ||
| Low Estimate | 3.65 M | 3.41 M | 3.14 M | 3.40 M | 4.05 M | 6.82 M | 3.86 M | 5.69 M | 5.36 M | 5.89 M | 4.79 M | 5.92 M | 9.16 M | 9.67 M | 7.41 M | 8.11 M | ||
| Consensus Estimate | 3.94 M | 3.64 M | 3.46 M | 3.53 M | 4.45 M | 7.53 M | 4.19 M | 5.98 M | 5.81 M | 6.29 M | 5.18 M | 6.25 M | 9.63 M | 10.39 M | 8.23 M | 8.55 M |
Analysts expect Vivos Therapeutics, Inc. to report earnings per share of -0.29 for Q3 26, against a range of -0.31 to -0.27. The most recent reported quarter, Q2 26, came in at -0.31, a 22.5% beat against the -0.40 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.40 | 0.41 | -0.45 | -0.55 | -0.49 | -0.58 | -0.52 | -0.31 | - | - | - | - | - | - | - | - | ||
| High Estimate | -0.59 | -0.36 | -0.37 | -0.35 | -0.45 | -0.43 | -0.43 | -0.37 | -0.27 | -0.18 | -0.54 | -0.55 | -0.23 | -0.06 | -0.53 | -0.47 | ||
| Low Estimate | -0.69 | -0.40 | -0.39 | -0.39 | -0.55 | -0.53 | -0.49 | -0.43 | -0.31 | -0.20 | -0.64 | -0.59 | -0.27 | -0.06 | -0.57 | -0.57 | ||
| Consensus Estimate | -0.64 | -0.38 | -0.38 | -0.37 | -0.50 | -0.48 | -0.46 | -0.40 | -0.29 | -0.19 | -0.59 | -0.57 | -0.25 | -0.06 | -0.55 | -0.52 |
Pull Wall Street consensus for Vivos Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VVOS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VVOS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VVOS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();